Fulcrum Therapeutics Inc (FULC)
$3.71 -1.59% Close Oct 30, 2026 Live
Fulcrum Therapeutics stock today
Fulcrum Therapeutics closed at $3.71 on October 30, 2026, down 1.59% on the day. Over the past year it returned -56.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $247 million.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | FULC | S&P 500 (SPY) |
|---|---|---|
| 1 month | +0.3% | -0.9% |
| 3 months | -0.3% | +2.1% |
| Year to date | -67.2% | +11.7% |
| 1 year | -56.9% | +12.4% |
| 3 years | +10.7% | +88.5% |
| 5 years | -83.2% | +76.0% |
Key statistics
- Market value
- $247M
- 52-week range
- $3.14 to $14.60
- Next report
- Nov 3, 2026 (estimated)
About Fulcrum Therapeutics
Develops small-molecule therapies targeting rare genetic and monogenic diseases.
Sector: Health Care
More on Fulcrum Therapeutics
- Financials: revenue, earnings and segmentsRevenue +2,752% in the year to Dec 2024
- Returns: what $1,000 became$1,000 five years ago is $167.57 today
No forecast, no recommendation. This page describes Fulcrum Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.